Market revenue in 2023 | USD 34,092.9 million |
Market revenue in 2030 | USD 66,066.1 million |
Growth rate | 9.9% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Infusion Pumps |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.23% in 2023. Horizon Databook has segmented the Asia Pacific drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to witness exponential growth over the forecast period due to increasing disposable income, improving healthcare infrastructure, and rapidly growing economic conditions in emerging economies such as Japan, China, & India. The large population with low per capita income in the Asia Pacific has led to a high demand for affordable treatment options.
Multinational companies are looking to invest in developing economies, such as India and China, to create a strong position in the market. Hence, numerous collaborative partnerships and strategic alliances are underway between key companies in this region, which is expected to create lucrative growth opportunities.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific drug device combination products market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account